| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |